INGN
Inogen, Inc.
Price Chart
Latest Quote
$6.77
+0.01 (+0.15%)
Current Price
| Previous Close | $6.76 |
| Open | $6.76 |
| Day High | $6.92 |
| Day Low | $6.76 |
| Volume | 69,826 |
Stock Information
| Shares Outstanding | 27.07M |
| Total Debt | $16.93M |
| Cash Equivalents | $110.17M |
| Revenue | $351.50M |
| Net Income | $-24.90M |
| Sector | Healthcare |
| Industry | Medical Devices |
| Market Cap | $183.29M |
| EPS (TTM) | $-0.91 |
| Exchange | NMS |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $89.79M |
| Sales | $351.50M |
| Income | $-24.90M |
| Book/sh | $6.68 |
| Cash/sh | $4.07 |
| Employees | 753 |
Financial Ratios
| Quick Ratio | 2.47 |
| Current Ratio | 3.10 |
| Debt/Eq | 9.26 |
Returns & Margins
| ROA | -6.14% |
| ROE | -13.07% |
| Gross Margin | 44.31% |
| Operating Margin | -9.89% |
| Profit Margin | -7.08% |
Ownership
| Insider Ownership | 12.64% |
| Institutional Ownership | 77.79% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -26.04 |
| P/S | 0.52 |
| P/B | 1.01 |
Analyst Data
| Recommendation | none |
| Target Price | $12.67 |
Technical Indicators
| SMA20 | $6.39 |
| SMA50 | $6.64 |
| SMA200 | $6.91 |
| RSI | 61.98 |
| ATR | 0.2518 |
| Shares Float | 23.65M |
| Short Float | 3.55% |
| Short Ratio | 2.60 |
| Volatility | 1.59 |
| Rel Volume | 0.21 |
Performance History
| Week | +6.28% |
| Month | +2.89% |
| Quarter | +5.45% |
| 6 Months | +0.30% |
| YTD | +2.11% |
| Year | -3.97% |
| 3 Years | -39.82% |
| 5 Years | -89.90% |
| 10 Years | -85.37% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-25 | $6.77 | 69,826 |
| 2026-06-24 | $6.76 | 211,300 |
| 2026-06-23 | $6.54 | 229,700 |
| 2026-06-22 | $6.43 | 260,500 |
| 2026-06-18 | $6.41 | 353,000 |
| 2026-06-17 | $6.37 | 238,400 |
| 2026-06-16 | $6.41 | 259,300 |
| 2026-06-15 | $6.46 | 173,100 |
| 2026-06-12 | $6.40 | 148,400 |
| 2026-06-11 | $6.30 | 308,400 |
| 2026-06-10 | $6.59 | 322,000 |
| 2026-06-09 | $6.35 | 529,600 |
| 2026-06-08 | $6.06 | 313,100 |
| 2026-06-05 | $6.41 | 467,000 |
| 2026-06-04 | $6.31 | 464,500 |
| 2026-06-03 | $5.98 | 438,300 |
| 2026-06-02 | $6.09 | 542,200 |
| 2026-06-01 | $6.09 | 609,700 |
| 2026-05-29 | $6.49 | 351,200 |
| 2026-05-28 | $6.54 | 215,700 |
| 2026-05-27 | $6.58 | 437,300 |
| 2026-05-26 | $6.58 | 311,500 |
About Inogen, Inc.
Inogen, Inc., a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally. The company offers portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. It provides Inogen One and Inogen Rove, an ambulatory solution for long-term oxygen therapy; Rove 4, a portable oxygen concentrator; Rove 6 concentrator; Inogen Voxi 5, a stationary oxygen concentrator; Aurora for continuous positive airway pressure; CPAP masks; Simeox for airway clearance treatment; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Beverly, Massachusetts.
đ° Latest News
Here's Why You Should Retain Inogen Stock in Your Portfolio for Now
Zacks âĸ 2026-06-25T14:12:00Z
How The Inogen (INGN) Story Is Shifting With New Targets And Execution Questions
Simply Wall St. âĸ 2026-05-11T00:18:06Z
INGN Stock Dips on Q1 Earnings Miss, Sales Up Y/Y, Gross Margin Improves
Zacks âĸ 2026-05-08T14:41:00Z
Inogen, Inc. Q1 2026 Earnings Call Summary
Moby âĸ 2026-05-08T12:30:00Z
Inogen Q1 Earnings Call Highlights
MarketBeat âĸ 2026-05-08T04:06:43Z
Inogen (INGN) Reports Q1 Loss, Beats Revenue Estimates
Zacks âĸ 2026-05-07T23:05:22Z
Neuronetics (STIM) Reports Q1 Loss, Tops Revenue Estimates
Zacks âĸ 2026-05-05T13:15:08Z
We're Not Very Worried About Inogen's (NASDAQ:INGN) Cash Burn Rate
Simply Wall St. âĸ 2026-04-28T10:28:07Z
Beta Bionics, Inc. (BBNX) Reports Q1 Loss, Misses Revenue Estimates
Zacks âĸ 2026-04-21T21:15:02Z
Inogen Unveils Growth Plan at Needham Conference: New CFO, Voxi 5, Simeox and Aurora Mask Push
MarketBeat âĸ 2026-04-16T08:03:35Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $194,403,000 | $180,964,000 | $188,961,000 | $223,708,000 |
| Cost Of Revenue | $194,403,000 | $180,964,000 | $188,961,000 | $223,708,000 |
| Total Revenue | $348,668,000 | $335,705,000 | $315,660,000 | $377,241,000 |
| Operating Revenue | $348,668,000 | $335,705,000 | $315,660,000 | $377,241,000 |
| Expenses | ||||
| Total Expenses | $378,875,000 | $378,221,000 | $392,152,000 | $410,323,000 |
| Rent Expense Supplemental | $18,768,000 | $19,717,000 | $17,432,000 | $14,800,000 |
| Other Income Expense | $2,443,000 | $850,000 | $-32,426,000 | $-53,023,000 |
| Other Non Operating Income Expenses | $2,443,000 | $850,000 | $468,000 | $-862,000 |
| Net Non Operating Interest Income Expense | $4,385,000 | $5,190,000 | $6,574,000 | $2,837,000 |
| Operating Expense | $184,472,000 | $197,257,000 | $203,191,000 | $186,615,000 |
| Selling And Marketing Expense | $97,692,000 | $103,069,000 | $107,091,000 | $120,767,000 |
| General And Administrative Expense | $67,381,000 | $72,578,000 | $75,260,000 | $43,905,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-22,747,000 | $-35,888,000 | $-102,449,000 | $-83,772,000 |
| Net Interest Income | $4,385,000 | $5,190,000 | $6,574,000 | $2,837,000 |
| Interest Income | $4,385,000 | $5,190,000 | $6,574,000 | $2,837,000 |
| Normalized Income | $-22,747,000 | $-35,888,000 | $-76,462,740 | $-42,564,810 |
| Net Income From Continuing And Discontinued Operation | $-22,747,000 | $-35,888,000 | $-102,449,000 | $-83,772,000 |
| Total Operating Income As Reported | $-30,207,000 | $-42,516,000 | $-109,386,000 | $-85,243,000 |
| Net Income Common Stockholders | $-22,747,000 | $-35,888,000 | $-102,449,000 | $-83,772,000 |
| Net Income | $-22,747,000 | $-35,888,000 | $-102,449,000 | $-83,772,000 |
| Net Income Including Noncontrolling Interests | $-22,747,000 | $-35,888,000 | $-102,449,000 | $-83,772,000 |
| Net Income Continuous Operations | $-22,747,000 | $-35,888,000 | $-102,449,000 | $-83,772,000 |
| Pretax Income | $-23,379,000 | $-36,476,000 | $-102,344,000 | $-83,268,000 |
| Special Income Charges | $0 | $0 | $-32,894,000 | $-52,161,000 |
| Interest Income Non Operating | $4,385,000 | $5,190,000 | $6,574,000 | $2,837,000 |
| Operating Income | $-30,207,000 | $-42,516,000 | $-76,492,000 | $-33,082,000 |
| Gross Profit | $154,265,000 | $154,741,000 | $126,699,000 | $153,533,000 |
| Per Share | ||||
| Diluted EPS | $-0.86 | $-1.52 | $-4.42 | $-3.67 |
| Basic EPS | $-0.86 | $-1.52 | $-4.42 | $-3.67 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $-6,907,740 | $-10,953,810 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-9,548,000 | $-21,512,000 | $-25,446,000 | $42,593,000 |
| Total Unusual Items | $0 | $0 | $-32,894,000 | $-52,161,000 |
| Total Unusual Items Excluding Goodwill | $0 | $0 | $-32,894,000 | $-52,161,000 |
| Reconciled Depreciation | $20,659,000 | $21,004,000 | $18,152,000 | $23,514,000 |
| EBITDA (Bullshit earnings) | $-9,548,000 | $-21,512,000 | $-58,340,000 | $-9,568,000 |
| EBIT | $-30,207,000 | $-42,516,000 | $-76,492,000 | $-33,082,000 |
| Diluted Average Shares | $26,601,652 | $23,654,395 | $23,176,098 | $22,852,571 |
| Basic Average Shares | $26,601,652 | $23,654,395 | $23,176,098 | $22,852,571 |
| Diluted NI Availto Com Stockholders | $-22,747,000 | $-35,888,000 | $-102,449,000 | $-83,772,000 |
| Tax Provision | $-632,000 | $-588,000 | $105,000 | $504,000 |
| Write Off | $0 | $0 | $32,894,000 | $0 |
| Research And Development | $19,399,000 | $21,610,000 | $20,840,000 | $21,943,000 |
| Selling General And Administration | $165,073,000 | $175,647,000 | $182,351,000 | $164,672,000 |
| Other Gand A | $67,381,000 | $72,578,000 | $75,260,000 | $43,905,000 |
| Gain On Sale Of Ppe | - | $0 | $0 | $-52,161,000 |
| Impairment Of Capital Assets | - | - | $32,894,000 | $0 |
Fetched: 2026-06-23
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $150,770,000 | $133,902,000 | $160,164,000 | $264,377,000 |
| Total Assets | $298,625,000 | $296,185,000 | $326,194,000 | $405,041,000 |
| Total Non Current Assets | $100,326,000 | $110,734,000 | $119,127,000 | $100,396,000 |
| Other Non Current Assets | $6,002,000 | $8,081,000 | $3,825,000 | $2,445,000 |
| Goodwill And Other Intangible Assets | $41,461,000 | $39,958,000 | $44,648,000 | $33,029,000 |
| Other Intangible Assets | $30,763,000 | $30,493,000 | $34,591,000 | $177,000 |
| Current Assets | $198,299,000 | $185,451,000 | $207,067,000 | $304,645,000 |
| Other Current Assets | $12,601,000 | $13,661,000 | $13,846,000 | $19,187,000 |
| Restricted Cash | $1,289,000 | $3,620,000 | $0 | - |
| Inventory | $25,969,000 | $24,812,000 | $21,840,000 | $34,093,000 |
| Receivables | $38,863,000 | $29,563,000 | $42,910,000 | $64,351,000 |
| Accounts Receivable | $38,863,000 | $29,563,000 | $42,241,000 | $62,725,000 |
| Allowance For Doubtful Accounts Receivable | $-478,000 | $-871,000 | $-2,820,000 | $-560,000 |
| Gross Accounts Receivable | $39,341,000 | $30,434,000 | $45,061,000 | $63,285,000 |
| Cash Cash Equivalents And Short Term Investments | $119,577,000 | $113,795,000 | $128,471,000 | $187,014,000 |
| Cash And Cash Equivalents | $103,729,000 | $113,795,000 | $125,492,000 | $187,014,000 |
| Cash Equivalents | $75,871,000 | $90,742,000 | $112,881,000 | $159,044,000 |
| Cash Financial | $27,858,000 | $23,053,000 | $12,611,000 | $27,970,000 |
| Taxes Receivable | - | $538,000 | $669,000 | $1,626,000 |
| Non Current Deferred Assets | - | - | - | - |
| Non Current Deferred Taxes Assets | - | - | - | - |
| Prepaid Assets | - | - | - | - |
| Debt | ||||
| Total Debt | $17,476,000 | $19,406,000 | $21,923,000 | $23,279,000 |
| Long Term Debt And Capital Lease Obligation | $14,313,000 | $16,594,000 | $18,270,000 | $19,764,000 |
| Current Debt And Capital Lease Obligation | $3,163,000 | $2,812,000 | $3,653,000 | $3,515,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $106,394,000 | $122,325,000 | $121,382,000 | $107,635,000 |
| Total Non Current Liabilities Net Minority Interest | $42,859,000 | $45,639,000 | $48,886,000 | $42,286,000 |
| Non Current Deferred Liabilities | $10,352,000 | $12,695,000 | $16,766,000 | $10,399,000 |
| Non Current Deferred Taxes Liabilities | $6,749,000 | $6,948,000 | $8,539,000 | $0 |
| Current Liabilities | $63,535,000 | $76,686,000 | $72,496,000 | $65,349,000 |
| Current Deferred Liabilities | $5,503,000 | $6,654,000 | $7,980,000 | $8,880,000 |
| Payables And Accrued Expenses | $44,753,000 | $44,484,000 | $41,235,000 | $45,164,000 |
| Payables | $20,820,000 | $16,758,000 | $13,481,000 | $18,729,000 |
| Other Payable | $373,000 | - | - | - |
| Total Tax Payable | $183,000 | $142,000 | $27,000 | $492,000 |
| Income Tax Payable | $183,000 | $142,000 | $27,000 | $0 |
| Accounts Payable | $20,264,000 | $16,616,000 | $13,454,000 | $18,237,000 |
| Other Current Liabilities | - | $13,000,000 | $10,000,000 | - |
| Other Non Current Liabilities | - | - | - | - |
| Equity | ||||
| Common Stock Equity | $192,231,000 | $173,860,000 | $204,812,000 | $297,406,000 |
| Total Equity Gross Minority Interest | $192,231,000 | $173,860,000 | $204,812,000 | $297,406,000 |
| Stockholders Equity | $192,231,000 | $173,860,000 | $204,812,000 | $297,406,000 |
| Gains Losses Not Affecting Retained Earnings | $4,243,000 | $-1,501,000 | $1,225,000 | $-243,000 |
| Other Equity Adjustments | $4,243,000 | $-1,501,000 | $1,225,000 | $-243,000 |
| Retained Earnings | $-175,584,000 | $-152,837,000 | $-116,949,000 | $-14,500,000 |
| Other | ||||
| Ordinary Shares Number | $27,232,350 | $23,902,338 | $22,941,643 | $22,941,643 |
| Share Issued | $27,232,350 | $23,902,338 | $22,941,643 | $22,941,643 |
| Tangible Book Value | $150,770,000 | $133,902,000 | $160,164,000 | $264,377,000 |
| Invested Capital | $192,231,000 | $173,860,000 | $204,812,000 | $297,406,000 |
| Working Capital | $134,764,000 | $108,765,000 | $134,571,000 | $239,296,000 |
| Capital Lease Obligations | $17,476,000 | $19,406,000 | $21,923,000 | $23,279,000 |
| Total Capitalization | $192,231,000 | $173,860,000 | $204,812,000 | $297,406,000 |
| Additional Paid In Capital | $363,545,000 | $328,174,000 | $320,513,000 | $312,126,000 |
| Capital Stock | $27,000 | $24,000 | $23,000 | $23,000 |
| Common Stock | $27,000 | $24,000 | $23,000 | $23,000 |
| Non Current Deferred Revenue | $3,603,000 | $5,747,000 | $8,227,000 | $10,399,000 |
| Long Term Capital Lease Obligation | $14,313,000 | $16,594,000 | $18,270,000 | $19,764,000 |
| Long Term Provisions | $18,194,000 | $16,350,000 | $13,850,000 | $12,123,000 |
| Current Deferred Revenue | $5,503,000 | $6,654,000 | $7,980,000 | $8,880,000 |
| Current Capital Lease Obligation | $3,163,000 | $2,812,000 | $3,653,000 | $3,515,000 |
| Current Provisions | $10,116,000 | $9,736,000 | $9,628,000 | $7,790,000 |
| Current Accrued Expenses | $23,933,000 | $27,726,000 | $27,754,000 | $26,435,000 |
| Goodwill | $10,698,000 | $9,465,000 | $10,057,000 | $32,852,000 |
| Net PPE | $52,863,000 | $62,695,000 | $70,654,000 | $64,922,000 |
| Accumulated Depreciation | $-48,964,000 | $-44,735,000 | $-47,845,000 | $-51,844,000 |
| Gross PPE | $101,827,000 | $107,430,000 | $118,499,000 | $116,766,000 |
| Other Properties | $101,827,000 | $107,430,000 | $118,499,000 | $116,766,000 |
| Finished Goods | $11,024,000 | $7,633,000 | $6,871,000 | $9,324,000 |
| Raw Materials | $14,945,000 | $19,224,000 | $18,036,000 | $26,496,000 |
| Other Short Term Investments | $15,848,000 | $0 | $2,979,000 | $0 |
| Inventories Adjustments Allowances | - | $-2,045,000 | $-3,067,000 | $-1,727,000 |
| Leases | - | - | - | $6,126,000 |
| Construction In Progress | - | - | - | $2,930,000 |
| Machinery Furniture Equipment | - | - | - | $12,756,000 |
| Land And Improvements | - | - | - | $125,000 |
| Properties | - | - | - | $0 |
Fetched: 2026-06-23
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-21,599,000 | $-11,179,000 | $-30,245,000 | $-58,754,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-11,216,000 | $5,914,000 | $-3,234,000 | $-37,532,000 |
| Cash Flow From Continuing Operating Activities | $-11,216,000 | $5,914,000 | $-3,234,000 | $-37,532,000 |
| Operating Gains Losses | $3,265,000 | $4,370,000 | $4,424,000 | $55,102,000 |
| Investing Activities | ||||
| Capital Expenditure | $-10,383,000 | $-17,093,000 | $-27,011,000 | $-21,222,000 |
| Investing Cash Flow | $-26,209,000 | $-13,975,000 | $-59,315,000 | $-10,877,000 |
| Cash Flow From Continuing Investing Activities | $-26,209,000 | $-13,975,000 | $-59,315,000 | $-10,877,000 |
| Net Other Investing Changes | - | $275,000 | $198,000 | $331,000 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $27,210,000 | $0 | $0 | - |
| Financing Cash Flow | $24,182,000 | $265,000 | $960,000 | $380,000 |
| Cash Flow From Continuing Financing Activities | $24,182,000 | $265,000 | $960,000 | $380,000 |
| Net Other Financing Charges | $-3,999,000 | $-546,000 | $-518,000 | $-1,355,000 |
| Net Common Stock Issuance | $27,210,000 | $0 | $0 | - |
| Common Stock Issuance | $27,210,000 | $0 | $0 | - |
| Other | ||||
| Income Tax Paid Supplemental Data | $320,000 | $375,000 | - | $499,000 |
| End Cash Position | $105,018,000 | $117,415,000 | $125,492,000 | $187,014,000 |
| Beginning Cash Position | $117,415,000 | $125,492,000 | $187,014,000 | $235,524,000 |
| Effect Of Exchange Rate Changes | $846,000 | $-281,000 | $67,000 | $-481,000 |
| Changes In Cash | $-13,243,000 | $-7,796,000 | $-61,589,000 | $-48,029,000 |
| Proceeds From Stock Option Exercised | $971,000 | $811,000 | $1,478,000 | $1,735,000 |
| Net Investment Purchase And Sale | $-15,826,000 | $2,843,000 | $-2,869,000 | $10,014,000 |
| Sale Of Investment | $14,003,000 | $35,500,000 | $24,000,000 | $10,014,000 |
| Purchase Of Investment | $-29,829,000 | $-32,657,000 | $-26,869,000 | $0 |
| Net Business Purchase And Sale | $0 | $0 | $-29,633,000 | $0 |
| Purchase Of Business | $0 | $0 | $-29,633,000 | $0 |
| Net Intangibles Purchase And Sale | $0 | $-2,090,000 | $-494,000 | $0 |
| Purchase Of Intangibles | $0 | $-2,090,000 | $-494,000 | $0 |
| Net PPE Purchase And Sale | $-10,383,000 | $-15,003,000 | $-26,517,000 | $-21,222,000 |
| Purchase Of PPE | $-10,383,000 | $-15,003,000 | $-26,517,000 | $-21,222,000 |
| Change In Working Capital | $-26,913,000 | $-4,390,000 | $14,269,000 | $-44,720,000 |
| Change In Other Working Capital | $-1,071,000 | $-1,198,000 | $490,000 | $5,037,000 |
| Change In Other Current Liabilities | $-13,131,000 | $-4,326,000 | $-3,456,000 | $-3,395,000 |
| Change In Other Current Assets | $4,931,000 | $4,405,000 | $2,303,000 | $3,483,000 |
| Change In Payables And Accrued Expense | $-1,106,000 | $2,923,000 | $-9,658,000 | $571,000 |
| Change In Accrued Expense | $-6,750,000 | $6,222,000 | $-508,000 | $-6,106,000 |
| Change In Payable | $5,644,000 | $-3,299,000 | $-9,150,000 | $6,677,000 |
| Change In Account Payable | $5,598,000 | $-3,414,000 | $-9,177,000 | $6,759,000 |
| Change In Tax Payable | $46,000 | $115,000 | $27,000 | $-82,000 |
| Change In Income Tax Payable | $46,000 | $115,000 | $27,000 | $-82,000 |
| Change In Prepaid Assets | $1,298,000 | $2,411,000 | $5,583,000 | $6,803,000 |
| Change In Inventory | $-3,210,000 | $-3,538,000 | $7,878,000 | $-5,601,000 |
| Change In Receivables | $-14,624,000 | $-5,067,000 | $11,129,000 | $-51,618,000 |
| Changes In Account Receivables | $-14,624,000 | $-5,187,000 | $10,141,000 | $-51,337,000 |
| Other Non Cash Items | $433,000 | $3,448,000 | $8,879,000 | $-15,386,000 |
| Stock Based Compensation | $8,014,000 | $7,397,000 | $7,427,000 | $12,283,000 |
| Provisionand Write Offof Assets | $7,173,000 | $11,123,000 | $13,421,000 | $15,447,000 |
| Asset Impairment Charge | $0 | $0 | $32,894,000 | $0 |
| Deferred Tax | $-1,100,000 | $-1,150,000 | $-251,000 | $0 |
| Deferred Income Tax | $-1,100,000 | $-1,150,000 | $-251,000 | $0 |
| Depreciation Amortization Depletion | $20,659,000 | $21,004,000 | $18,152,000 | $23,514,000 |
| Depreciation And Amortization | $20,659,000 | $21,004,000 | $18,152,000 | $23,514,000 |
| Gain Loss On Sale Of PPE | $57,000 | $-165,000 | $-84,000 | $52,007,000 |
| Net Income From Continuing Operations | $-22,747,000 | $-35,888,000 | $-102,449,000 | $-83,772,000 |
Fetched: 2026-06-23